Avantor, Inc.

Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company that serves as a global provider of mission-critical products and services to the life sciences and advanced technology industries. Headquartered in Radnor, Pennsylvania, the company's mission is to "set science in motion to create a better world."

The company's extensive portfolio includes a wide range of materials and consumables, such as ultra-high-purity chemicals, reagents, laboratory supplies, formulated silicone materials, customized excipients, and single-use assemblies. Avantor also provides equipment and instrumentation, including filtration systems and analytical instruments, alongside specialized services like onsite lab management, procurement, and biopharmaceutical material scale-up and development. These offerings cater to key market segments including biopharma, healthcare, education & government, and advanced technologies & applied materials, operating primarily through its Laboratory Solutions and Bioscience Production segments.

Emmanuel Ligner serves as the President and Chief Executive Officer of Avantor. Recent developments include the appointment of Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory in May 2026, and Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer in April 2026. The company reported its first-quarter 2026 results in April 2026 and has been enhancing its U.S. biomanufacturing infrastructure. While positioned as a leading global provider, Avantor faces market headwinds, including cautious customer spending and funding challenges in early-stage biotech, which led to a revised full-year 2025 guidance.